Skylar Woolman

629 citations
8 papers · 491 · h-index 6

Impact in

  • Immunology top 10%
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
    • Immune Cell Function and Interaction
    • interferon and immune responses
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
    • CAR-T cell therapy research

Papers in

    • Cancer Immunotherapy and Biomarkers 5
    • Chemokine receptors and signaling 1
    • Histone Deacetylase Inhibitors Research 2
    • Single-cell and spatial transcriptomics 1
    • Melanoma and MAPK Pathways 1

Skylar Woolman

8 papers receiving 486 citations

Peers

Skylar Woolman
Comparison fields: 5 of 48
  • Immunology 317
  • Oncology 342
  • Cancer Research 51
  • Molecular Biology 156
  • Infectious Diseases 28
Replace Kayla Cruz with:
Kayla Cruz United States
Emily F. Higgs United States
Sreevani Arisa United States
Ben Wylie Australia
Nao Fujieda Japan
Anthony Leonardi United States
Rebecca C. Obeng United States
Ivan Perrot France
Gabriela M. Wiedemann Germany
Jean David Fumet France
Skylar Woolman relative to Kayla Cruz United States Kayla Cruz's profile →
Citations per field
00.5×1.5×
Kayla Cruz · 1×
Citations per year

Countries citing papers authored by Skylar Woolman

Since Specialization
Citations

This map shows the geographic impact of Skylar Woolman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Skylar Woolman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Skylar Woolman more than expected).

Fields of papers citing papers by Skylar Woolman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Skylar Woolman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Skylar Woolman. The network helps show where Skylar Woolman may publish in the future.

Co-authors

The 25 scholars most cited alongside Skylar Woolman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Skylar Woolman Line = papers co-authored together Skylar Woolman links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 2018161
2 2018132
3 201994
4 202150
5 202033
6 202117
7 20183
8 20211

About Skylar Woolman

Skylar Woolman is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 8 papers that have together received 491 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers), Histone Deacetylase Inhibitors Research (2 papers), Immune cells in cancer (2 papers), Single-cell and spatial transcriptomics (1 paper), Cancer Genomics and Diagnostics (1 paper), Chemokine receptors and signaling (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Immunology (317 citations), Oncology (342 citations), Cancer Research (51 citations), Molecular Biology (156 citations) and Infectious Diseases (28 citations). Skylar Woolman has collaborated with scholars based in United States. Frequent co-authors include Elizabeth M. Jaffee, Kayla Cruz, Todd D. Armstrong, Brian J. Christmas, Blake Scott, Evanthia T. Roussos Torres, S. Hayley, Alexander C. Hopkins, Mark Yarchoan and Neeha Zaidi. Their work appears in journals such as Cancer Immunology Research, JCI Insight, Cancer Research and Genome biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact